Identity
- Security key
- 22301
- Ticker
- TAOX
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2020-12-07
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- TAOX
Detail
Enriched 2026-08-14 20:47
- Market cap
- $26,002,319.88
- Shares outstanding (class)
- 7,471,931
- Shares outstanding (weighted)
- 7,471,931
- SIC
- 6199 FINANCE SERVICES
- Employees
- 4
- Location
- NEW YORK, NY
- Homepage
- https://www.taosynergies.com
- Description
TAO Synergies Inc is mainly focused on developing a product platform based on its drug candidate, Bryostatin-1, for the treatment of Alzheimer's disease. The company is also evaluating Bryostatin-1 for other neurodegenerative and cognitive conditions, including Fragile X syndrome and Multiple Sclerosis, which have progressed through pre-clinical testing.